(Updated - July 17, 2017 4:32 PM EDT)On July 17, 2017, the U.S. Food and Drug Administration approved neratinib (NERLYNX ...(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Puma Biotechnology (PBYI) PT Raised to $118 at Stifel; Broad Label Can Increase Attractiveness to Potential Suitors

July 18, 2017 6:12 AM

Puma Biotech (PBYI) Surges 10% as Trading Resumes Following FDA Approval

July 17, 2017 5:57 PM

Puma Biotech (PBYI) to Resume Trading at 5:55 PM ET

July 17, 2017 5:41 PM

Puma Biotech (PBYI) Confirms FDA Approval of NERLYNX for Extended Adjuvant Treatment of HER2-Positive Early Stage Breast Cancer

July 17, 2017 5:37 PM

Puma Biotech (PBYI) Isn't Disclosing Nerlynx Price Right Now - CNBC

July 17, 2017 5:24 PM

Puma Biotech (PBYI) Halt May be Tied to FDA Decision on Neratinib; Estimated Decision Date is July 21

July 17, 2017 3:44 PM

Puma Biotech (PBYI) call put ratio 2.25 calls to 1 put as shares sell off 3.8% into trading halt

July 17, 2017 3:42 PM

UPDATE: Puma Biotech (PBYI) Halted for Trading Into Neratinib PDUFA

July 17, 2017 3:38 PM